Sbir topic 294 phase 1 - development of glycosylation - specific research

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201100078C
Awardee
Awarding agency
Obligated
$148,569

Award facts

Contract value 100% obligated
$148,569.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 14 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Clayton, MO 63124, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $148,569

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract is for the development of glycosylation-specific research under SBIR Topic 294, with a ceiling value of $148,569. SBIR contracts are set-aside for small businesses to engage in research and development for the government. This Phase I contract represents the initial research and feasibility stage of the SBIR program. The ultimate completion date for this contract is June 14, 2012.

Quick answers

Who was awarded contract HHSN261201100078C?

HHSN261201100078C was awarded to Mediomics LLC by National Cancer Institute (National Institutes of Health) on September 15, 2011.

How much is contract HHSN261201100078C worth?

The government has obligated $148,569 on HHSN261201100078C.

Was contract HHSN261201100078C competed?

The extent of competition for HHSN261201100078C was full and open competition after exclusion of sources. The government received 14 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award